HIGHLIGHTS
- who: Neda Anastassova and collaborators from the Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, and, Faculty of Pharmacy, Medical University-Sofia, Dunav Str have published the Article: Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson’s Disease, in the Journal: Antioxidants 2022, 884 of /2022/
- what: __SECTION__ Conclusions.
- how: The obtained results indicated that all tested compounds possess the capability to influence lecithin oxidative damage to a different extent depending on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.